MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 31 - per page Next page
Order by
On 28 April 2006 the EU Council adopted a Regulation on the compulsory licensing of patents and supplementary protection certificates (SPCs). More
The global biopharma market continues to expand and is predicted to continue doing so for many years to come. A review of recent financial and biopharma press coverage indicates that mergers and acquisitions remain prevalent within this industry. More
This article considers the potential impact for the international pharmaceutical and biotechnology industries of decisions from a US and a UK court given within a week of each other in October 2004. More
The Cooperative Research and Technology Enhancement ("CREATE") Act of 2004 was signed into law by President Bush on December 10, 2004. More
Recently enacted changes to pharmaceutical law in Japan provide significant opportunities for non-Japanese companies to increase their market presence in the country and provide manufacturing services to its pharmaceutical industry More
More law firms than ever before are now targeting the life sciences industry, and those with traditional ties appear to be approaching the sector with renewed vigour. More
Concern among European fine chemicals companies over the large volume of illicit active pharmaceutical ingredients (APIs) imported into the European Union (EU) should be dampened by stricter EU regulations on the licensing of medicines. More
A detailed account of all the actions required to prove when you made your invention More
Judging by some of the more pessimistic coverage, the enlargement of the European Union (EU) will open the gates to a flood of cheap imports from accession countries to existing member states. More
The introduction of a single EU-wide patent, with a single enforcement system, has been the subject of debate for more than 30 years. Now, at last, it looks like becoming a reality. More
Displaying 1..10 of 31 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us